Stock·NYSE·Utilities
Sempra (SRE)
- Market cap
- $54.54B
- P/E
- 23.70
- Dividend yield
- 3.14%
- Street target
- $99.00median of 20 analysts
- 52-week range
- $76.21 $101.04
The short version
Where SRE stands today, in four lines, and what CleaRank Financial AI makes of it.
SRE at a glance
Sempra (SRE): Hold, 52/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($82.54 and $89.69).
- Earnings SRE beat estimates in 5 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $13.3M and bought $577K over the last 18 months.
- Valuation P/E of 23.7 against 22.8 for the Utilities sector: broadly in line with peers (+4%).
Figures as of October 16, 2026.
CleaRank Financial AI
Sempra (SRE) carries a CleaRank rating of Hold and a model score of 52/100.
Analysts are the biggest support: 16 of 20 rate the stock a buy, and the median target is 18.7% above the price. The trend is the largest drag, with the price 7.00% below its 200-day average and the 50-day average 7.97% below the 200-day. Those averages currently read $82.54 for the 50-day and $89.69 for the 200-day. Across the past year, the price declined 8.48%.
Only on CleaRank
Figures we compute ourselves from SRE's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $83.41 is 1.1% above the 50-day simple moving average of $82.54.Price above its 200-day average ›
The price is 7.0% below the 200-day simple moving average of $89.69.50-day average above the 200-day ›
The 50-day average ($82.54) is 8.0% below the 200-day average ($89.69), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 29% of its 52-week range, between $76.21 and $101.04.
SRE share price
Pick a period: each tab shows how far SRE has moved over it, to the last close.
Today's trading
Where SRE sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 23.70 is 3.9% above the Utilities median of 22.8.P/S below the sector median ›
The price-to-sales ratio of 3.96 is 19.9% above the sector median of 3.3.Profitable over the last 12 months ›
Net income over the last 12 months was $2.3B on revenue of $13.6B, a net margin of 16.7%.Beat estimates in most recent reports ›
SRE beat the EPS estimate in 5 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 3.14%, or $2.62 a share a year.
Key statistics
The headline figures for SRE.
As of October 16, 2026, SRE trades at $83.41, with a market value of $54.54B, a P/E ratio of 23.70 and a dividend yield of 3.14%.
What the numbers say
CleaRank Financial AI's reading of SRE's valuation, growth and risks.
Sempra (SRE) trades on a trailing P/E of 23.70, which is 3.9% above the Utilities median of 22.8. The Peer Benchmarking card calls the P/E broadly in line with peers. On sales, SRE is priced at 3.96 times, 20.0% above the sector median of 3.3. The company has a market capitalisation of $54.5B and trailing earnings of $3.46 per share.
With a revenue decline of 0.10%, SRE is 4.2 percentage points slower than the sector median of 4.1%. SRE turns sales into profit at a net margin of 16.82% and an operating margin of 28.33%, alongside a return on equity of 6.68%, below the sector median of 9.6%. The balance sheet and payout round out the picture, with debt-to-equity of 0.85 and a trailing dividend yield of 3.14% ($2.62 a share a year).
Sempra (SRE) reported EPS of $1.16 in the August 6, 2026 report, against an estimate of $1.06, a beat of 9.43%. Even so, the stock fell 0.56% in the next session.
SRE beat the EPS estimate in 5 of its last 8 reports; even so, 3 of those 5 beats were followed by a lower share price the next session. Analysts' average EPS estimate for this fiscal year is $5.11, which would be growth of 8.9%, and $5.54 for next year (growth of 8.5%).
SRE's average daily move is 1.14%. The price sits 17.45% below the 52-week high of $101.04. Over the last 18 months insiders sold $13.3M and bought $577K. Insider sales of this kind are often planned in advance, so they carry less weight than purchases would.
SRE against the Utilities sector
How SRE compares with the median Utilities stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (4% difference), suggesting fair market pricing relative to industry standards.
Return vs XLU: Since May 6, 2025, SRE has gained 11.1% against a gain of 4.8% for XLU.
Performance against XLU
SRE and the Utilities sector fund over the same days.
Revenue and earnings
How much SRE sells, and how much of it becomes profit.
Revenue growth: Revenue grew 3.9% in FY2025 to $13.7B, from $13.2B a year earlier.
Profit margin: The net margin was 15.1% in FY2025, down from 26.5% the year before.
Profitable: SRE earned $2.1B in FY2025.
Earnings reality check
Did SRE beat what analysts expected, and how did the stock react?
Earnings record: SRE beat the analyst estimate in 5 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $1.06 | $1.16 | +9.43% | -0.56% | +2.53% |
| May 7, 2026after close | $1.51 | $1.51 | +0.00% | -0.04% | +1.41% |
| Feb 26, 2026after close | $1.17 | $1.28 | +9.40% | +1.12% | -1.32% |
| Nov 5, 2025after close | $0.91 | $1.11 | +21.98% | +0.42% | +0.09% |
| Aug 7, 2025after close | $0.85 | $0.89 | +4.71% | -1.07% | -0.86% |
| May 8, 2025after close | $1.32 | $1.44 | +9.09% | -0.46% | +0.92% |
| Feb 25, 2025after close | $1.55 | $1.50 | -3.23% | +3.13% | -0.01% |
| Nov 6, 2024after close | $1.07 | $0.89 | -16.82% | +1.70% | +4.45% |
As of October 16, 2026, SRE has beaten the analyst EPS estimate in 5 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on August 6, 2026, came in 9.43% above the estimate and the stock moved -0.56% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 60.8, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 60.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of SRE
The score, the reasoning behind it, and what could move the price next.
Sempra (SRE) shows a mixed trend. At $83.41, the stock is 1.05% above its 50-day average of $82.54, yet 7.00% below its 200-day average of $89.69. Near the bottom of its 52-week range, the price is 9.45% above the low of $76.21 and 17.45% below the high of $101.04. Both averages lag the price, and the 50-day sits 7.97% below the 200-day.
Recent gains sit against a weaker longer record: the price rose 2.09% over the past month, fell 9.58% over the past three months and fell 8.48% over the past year. The 14-day RSI of 60.8 is in the bullish zone, below the overbought line, while the MACD line is negative, so the two momentum readings point different ways. Volume in the last session ran 83.4% above its average, on a day the price rose 1.81%.
Analyst upgrade ›
Jefferies upgraded it to Buy from Hold on September 1, 2026.
Source: Analyst action, Jefferies, September 1, 2026New analyst coverage ›
Scotiabank started coverage at Sector Perform on September 29, 2026.
Source: Analyst action, Scotiabank, September 29, 2026
Earnings beat ›
The August 6, 2026 report beat the EPS estimate by 9.43%, and the share price fell 0.56% in the first session after it.
Source: Earnings report, August 6, 2026
- Keep an eye on the two nearest levels: the 200-day SMA at $89.69 sits above the price, and the 50-day SMA at $82.54 sits below it.
- The 14-day RSI reads 60.8, in the bullish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price fell 0.56% in the first session after the August 6, 2026 report. Over the last 8 reports, SRE beat estimates in 5.
SRE's trend gives mixed signals, sitting above its 50-day average of $82.54 while remaining under its 200-day average of $89.69. If the price closed above the 200-day, both readings would point up. A close below the 50-day would flip both to down. For now, the nearest level underneath is the 50-day SMA at $82.54, and the nearest one overhead is the 200-day SMA at $89.69.
With the RSI in the bullish zone, momentum still supports the move.
Technical indicators
Momentum and trend for SRE, from its daily closes.
As of October 16, 2026, with SRE at $83.41, its 14-day RSI is 60.8 (showing bullish momentum without being overbought), its 50-day simple moving average is $82.54 and its 200-day is $89.69.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What SRE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, SRE's 1-year correlation of daily returns is +0.31 with S&P 500 (SPY), +0.22 with Nasdaq 100 (QQQ), +0.02 with Bitcoin (BTC) and +0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
16 of 20 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $99.00 is 18.7% above the price.More buy ratings than three months ago ›
16 of 20 rate it a buy now, against 15 of 20 three months ago.
SRE Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | JP Morgan | Maintains | Overweight |
| Sep 29, 2026 | Scotiabank | Initiates | Sector Perform |
| Sep 18, 2026 | Morgan Stanley | Maintains | Overweight |
| Sep 3, 2026 | Truist Securities | Maintains | Buy |
| Sep 2, 2026 | JP Morgan | Maintains | Overweight |
| Sep 1, 2026 | Jefferies | Upgrade | Buy |
As of October 16, 2026, 20 Wall Street analysts cover SRE: 16 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $83.00 to $118.00, with a median of $99.00, 18.7% above the price of $83.41.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
SRE trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from SRE's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much SRE tends to move, against the market and on its own.
The long record
SRE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.14% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 36.8%, from February 2020 to March 2020, regained by March 2022.Most 1-year holds ended higher ›
74% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $21,448, against $42,525 in the S&P 500 (SPY).
SRE Drawdowns & Recovery
As of October 16, 2026, SRE's worst peak-to-trough fall over the last 10 years with dividends reinvested was -36.8% (February 2020 to March 2020); it regained that peak by March 2022, 24 months after the low, and 74% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into SRE in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: SRE trailed the S&P 500 over this period: $21,448 against $42,525.
A $10,000 investment in SRE in October 2016 would be worth about $21,448 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to SRE, and which have not.
Strongest month, April: an average of +2.57%, up in 8 of 10 years.
Weakest month, December: an average of -2.21%, up in 3 of 10 years.
This month, October: has averaged +1.77%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, SRE's strongest calendar month has been April (average +2.57%, up in 8 of 10 years) and its weakest December (average -2.21%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in SRE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in SRE today could grow to about $17,118 by 2036 in the base case, with a 90th-percentile outcome near $47,675 and a 10th-percentile outcome around $6,146. The simulation models price only; at today's 3.14% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
SRE Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $103 for SRE by 2030 in the base case, from $83.41 today (1.2x over 4 years). The 10th-percentile path ends near $54.11. These are outcomes of a Monte Carlo simulation run on SRE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $63.66 | $88.02 | $122 | |
| 2028 | $58.74 | $92.88 | $147 | |
| 2029 | $55.92 | $98.01 | $172 | |
| 2030 | $54.11 | $103 | $198 | |
| 2031 | $52.89 | $109 | $225 |
Method: a lognormal simulation of SRE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
SRE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $577K on the open market and sold $13.3M.
As of October 16, 2026, SRE insiders reported 16 open-market sales worth $13.3M and 3 open-market purchases worth $577K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Caroline Ann Winn
Officer
|
Sell | 8.0K | $724.4K |
| May 18, 2026 | Pablo A Ferrero
Director
|
Sell | 2.6K | $232.8K |
| May 14, 2026 | Diana L Day
Officer
|
Sell | 3.3K | $304.0K |
| May 12, 2026 | Andres Conesa
Director
|
Grant | 1.5K | - |
| May 12, 2026 | Pablo A Ferrero
Director
|
Grant | 1.5K | - |
| May 12, 2026 | Richard J Mark
Director
|
Grant | 1.5K | - |
| May 12, 2026 | Anya Weaving
Director
|
Grant | 1.5K | - |
| Apr 1, 2026 | Justin Christopher Bird
Officer
|
Sell | 1.1K | $109.1K |
| Mar 16, 2026 | Dyan Z. Wold
Officer
|
Sell | 1.5K | $146.8K |
| Mar 12, 2026 | Jennifer M Kirk
Director
|
Buy | 1.0K | $93.4K |
| Mar 11, 2026 | Richard J Mark
Director
|
Buy | 2.7K | $251.2K |
| Mar 11, 2026 | Cynthia J Warner
Director
|
Buy | 2.5K | $232.4K |
| Mar 9, 2026 | Karen L Sedgwick
Chief Financial Officer
|
Sell | 4.9K | $451.0K |
| Jan 27, 2026 | Justin Christopher Bird
Officer
|
Grant | 4.9K | - |
| Jan 27, 2026 | Diana L Day
Officer
|
Grant | 1.8K | - |
| Jan 27, 2026 | Alexander Lisa Larroque
Officer
|
Grant | 1.7K | - |
| Jan 27, 2026 | Jeffrey W Martin
Chief Executive Officer
|
Grant | 38.3K | - |
| Jan 27, 2026 | Kevin C Sagara
Director
|
Grant | 7.5K | - |
| Jan 27, 2026 | Karen L Sedgwick
Chief Financial Officer
|
Grant | 5.2K | - |
| Jan 27, 2026 | Caroline Ann Winn
Officer
|
Grant | 4.5K | - |
| Jan 27, 2026 | Dyan Z. Wold
Officer
|
Grant | 736 | - |
| Jan 5, 2026 | Jeffrey W Martin
Chief Executive Officer
|
Sell | 53.1K | $4.7M |
| Jan 2, 2026 | Diana L Day
Officer
|
Grant | 9.4K | - |
| Jan 2, 2026 | Alexander Lisa Larroque
Officer
|
Grant | 5.8K | - |
| Jan 2, 2026 | Dyan Z. Wold
Officer
|
Grant | 2.9K | - |
| Nov 24, 2025 | Karen L Sedgwick
Chief Financial Officer
|
Sell | 7.6K | $698.1K |
| Nov 19, 2025 | Caroline Ann Winn
Officer
|
Sell | 6.0K | $549.5K |
| Nov 19, 2025 | Dyan Z. Wold
Officer
|
Sell | 1.5K | $138.0K |
| Nov 7, 2025 | Alexander Lisa Larroque
Officer
|
Sell | 4.3K | $400.0K |
| Sep 29, 2025 | Kevin C Sagara
Director
|
Sell | 14.4K | $1.3M |
| Sep 15, 2025 | Kevin C Sagara
Director
|
Sell | 28.9K | $2.4M |
| Aug 14, 2025 | Caroline Ann Winn
Officer
|
Sell | 5.1K | $419.4K |
| Jul 23, 2025 | Alexander Lisa Larroque
Officer
|
Sell | 1.6K | $126.1K |
| May 14, 2025 | Diana L Day
Officer
|
Sell | 8.0K | $595.2K |
| May 13, 2025 | Andres Conesa
Director
|
Grant | 1.9K | - |
| May 13, 2025 | Pablo A Ferrero
Director
|
Grant | 1.9K | - |
| May 13, 2025 | Richard J Mark
Director
|
Grant | 1.9K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.